Private equity firm EQT launches $654 mln cash bid for Sweden’s Karo Pharma
STOCKHOLM: Private equity firm EQT on Monday made a recommended 5.97 billion Swedish crown ($654 million) cash bid to buy Swedish specialty pharma group Karo Pharma. The offer, made by…
Glenmark gets USFDA nod for generic skin inflammation oil
New Delhi: Glenmark Pharmaceuticals Friday said its US arm has received final nod from the US health regulator for generic Fluocinolone Acetonide Topical oil used for treatment of inflammation of…
Gilead hepatitis C drug sales fall, but profit beats estimates
By Deena Beasley Second quarter sales of Gilead Sciences Inc’s flagship hepatitis C drugs fell by more than half as competition increased, sending net profit down 22 percent from a…
US approves first new type of flu drug in 2 decades
TRENTON, N.J: U.S. health regulators have approved the first new type of flu drug in two decades. Wednesday’s approval of Xofluza for people age 12 and older comes ahead of…
Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain
By Manojna Maddipatla and Tamara Mathias A non-opioid drug developed by Pfizer and Eli Lilly met the main goals of a late-stage study, in which over half of the patients…
Sun Pharma launches psoriasis treatment drug Ilumya in US
Sun Pharmaceutical Industries Tuesday said it has launched its plaque psoriasis treatment drug Ilumya (tildrakizumab-asmn) in the US market.Ilumya in the strength of 100 mg/mL is now available in the…
Johnson and Johnson asked to cut down price of new TB drug
Medicines Sans Frontiers (MSF) has called upon US drug maker c (J&J) to cut down the price of its new tuberculosis drug Bedaquiline, as the high price of the drug…
Mumbai: PIL against antibiotics’ sale without prescription
MUMBAI: A lawyer has filed a PIL in the Bombay HC against the Union and state governments, Central Drugs Standard Control Organization (CDSCO) and drug regulator to prevent the rampant…
Pharma co buys Rs 350-cr plot
One of the biggest pharmaceutical companies in the country is moving its corporate headquarters. And, in doing so, it has given a fillip to the city’s realty market by buying…
Merck KGaA says might strike partnership deal this year
MUNICH: German drugmaker Merck KGaA might agree partnership deals to jointly develop two of its most promising experimental medicines with a rival as early as this year, but more likely…
